Abstract:a-Arylcyclobutanones displayunique reactivity that makes them valuable synthetic intermediates and target molecules.W ed escribe the preparation of a-aryl-and aheteroarylcyclobutanones through ad irect a-arylation reaction. Problematic fragmentations are avoided by the use of LiO t Bu, whichp romotes ar apid but reversible self-aldol reaction that slowly releases the enolate required for aarylation. We also demonstrate the ring expansion of aarylcyclobutanones,aprocess that is highlighted in the stereoselectiv… Show more
“…Attempts to proceed the Ni-catalyzed arylation of the achloroketone 20 met with failure. [21] Under the conditions reported by Britton and co-workers for the arylation of cyclobutanones [(D t BPF)PdCl 2 ,L iO t Bu, 4-bromoanisole, THF,6 0 8 8C], [22] a-arylcyclobutanone 21 was obtained from cyclobutanone 13 in 23 %y ield due to the poor diastereoselectivity. In the first route for the synthesis of the tricyclic core of 1, 19 from 7 (Scheme 3), intermolecular [2+ +2] thermal cycloaddition between dichloroketene and trisubstituted alkene was applied to assemble dichlorocyclobutanones.A lthough Shapiro coupling reaction followed by 1,4-addition furnished the key intermediate with af unctionalized cyclobutane core bearing two chiral centers,t he mismatched C8' stereochemistry and the subsequent operation of configuration inversion significantly lowered the overall efficiency.T herefore,w e explored an alternative strategy in which a-arylcyclobutanones were first established, followed by face-selective homologation to access the key cyclobutane skeleton with four chiral centers.W ith these thoughts in mind, we undertook aretrosynthetic analysis of 1 (Figure 6).…”
Section: First Route For the Synthesis Of The Tricyclic Core Of 1through Ketene-based [2+ +2] Cycloadditionmentioning
Isoscopariusin Aw as isolated from the aerial parts of Isodon scoparius.C hemical synthesis and spectroscopic analysis established its structure as an unsymmetrical meroditerpenoid bearing as terically congested 6/6/4 tricyclic carbon skeleton with seven continuous stereocenters.Agramscale synthesis was achieved in 12 steps from commercially available (+ +)-sclareolide.Acobalt catalyzed, hydrogen atom transfer-based olefin isomerization was used to prepare at risubstituted alkene,w hichu nderwent stereoselective [2+ +2] cycloaddition with asubstituted keteniminium ion generated in situ from the corresponding amide.T he cyclobutanone product was further elaborated into the fully substituted cyclobutane core through face-selective homologation, and the two side chains were installed by using nickel-catalyzed crosselectrophile coupling and carbodiimide-mediated esterification, respectively.( À)-Isoscopariusin Ad isplayed selective inhibition of T-cell proliferation.
“…Attempts to proceed the Ni-catalyzed arylation of the achloroketone 20 met with failure. [21] Under the conditions reported by Britton and co-workers for the arylation of cyclobutanones [(D t BPF)PdCl 2 ,L iO t Bu, 4-bromoanisole, THF,6 0 8 8C], [22] a-arylcyclobutanone 21 was obtained from cyclobutanone 13 in 23 %y ield due to the poor diastereoselectivity. In the first route for the synthesis of the tricyclic core of 1, 19 from 7 (Scheme 3), intermolecular [2+ +2] thermal cycloaddition between dichloroketene and trisubstituted alkene was applied to assemble dichlorocyclobutanones.A lthough Shapiro coupling reaction followed by 1,4-addition furnished the key intermediate with af unctionalized cyclobutane core bearing two chiral centers,t he mismatched C8' stereochemistry and the subsequent operation of configuration inversion significantly lowered the overall efficiency.T herefore,w e explored an alternative strategy in which a-arylcyclobutanones were first established, followed by face-selective homologation to access the key cyclobutane skeleton with four chiral centers.W ith these thoughts in mind, we undertook aretrosynthetic analysis of 1 (Figure 6).…”
Section: First Route For the Synthesis Of The Tricyclic Core Of 1through Ketene-based [2+ +2] Cycloadditionmentioning
Isoscopariusin Aw as isolated from the aerial parts of Isodon scoparius.C hemical synthesis and spectroscopic analysis established its structure as an unsymmetrical meroditerpenoid bearing as terically congested 6/6/4 tricyclic carbon skeleton with seven continuous stereocenters.Agramscale synthesis was achieved in 12 steps from commercially available (+ +)-sclareolide.Acobalt catalyzed, hydrogen atom transfer-based olefin isomerization was used to prepare at risubstituted alkene,w hichu nderwent stereoselective [2+ +2] cycloaddition with asubstituted keteniminium ion generated in situ from the corresponding amide.T he cyclobutanone product was further elaborated into the fully substituted cyclobutane core through face-selective homologation, and the two side chains were installed by using nickel-catalyzed crosselectrophile coupling and carbodiimide-mediated esterification, respectively.( À)-Isoscopariusin Ad isplayed selective inhibition of T-cell proliferation.
A Pd‐catalyzed fluoroarylation of gem‐difluoroalkenes with aryl halides is reported. By taking advantage of the in situ generated α‐CF3‐benzylsilver intermediates derived from the nucleophilic addition of silver fluoride to gem‐difluoroalkenes, this strategy bypasses the use of a strong base, thus enabling a mild and general synthetic method for ready access to non‐symmetric α,α‐disubstituted trifluoroethane derivatives.
The enantioselective intramolecular α‐arylation of cyclobutanones has been established by combining palladium and enamine catalyst systems. Two different enantioselective control strategies have been developed for cyclobutanone substrates bearing O‐ or N‐tethered aryl bromides. Further synthetic applications are also reported.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.